SCHEMBL24291007

SCHEMBL24291007

c1ccc(-n2c3ccccc3c3c2ccc2c4cccnc4c4nc5ccccc5n4c23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.39
MAPT P10636 3/20 0.39
LMNA P02545 2/20 0.39
POLB P06746 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TP53 P04637 1/20 0.39
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 6/20 0.38
HPGD P15428 6/20 0.38
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
CYP2C19 P33261 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CASP1 P29466 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24290339 0.91 KDM4E (0.41) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL24291034 0.90 KDM4E (0.41) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL24291031 0.89 KDM4E (0.39) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL24291269 0.87 KDM4E (0.41) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL21298408 0.86 KDM4E (0.39) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL23948220 0.86 KDM4E (0.36) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL21890437 0.86 KDM4E (0.47) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL21890167 0.83 KDM4E (0.35) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL24290341 0.83 KDM4E (0.42) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL23948640 0.82 KDM4E (0.44) KDM4EMAPTLMNAPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220073517-A1 BLUE THERMALLY ACTIVATED DELAYED FLUORESCENT EMITTERS AND HOSTS BASED ON FUNCTIONALIZED IMIDAZOLYL GROUPS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2022-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220073517-A1 BLUE THERMALLY ACTIVATED DELAYED FLUORESCENT EMITTERS AND HOSTS BASED ON FUNCTIONALIZED IMIDAZOLYL GROUPS IK, ETFA, GDI1 KDM4E 3679/4885MAPT 690/4885LMNA 2844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.